Consensus on Familial Hypercholesterolaemia in Children and Adolescents

Familial Hypercholesterolaemia in children and adolescents: gaining decades of life by optimising detection and treatment Consensus Statement of the European Atherosclerosis Society Publication in full Featured Commentary Slide set Authors Wiegman A, Gidding SS, Watts GF, Chapman MJ, Ginsberg HN, Cuchel M, Ose L, Averna M, Boileau C, Borén J, Bruckert E, Catapano AL, Defesche … Read more

Consensus on FH

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease Consensus Statement of the European Atherosclerosis Society Publication in full Slide set Featured Commentary Authors Børge G. Nordestgaard*, M. John Chapman*, Steve E. Humphries, Henry N. Ginsberg, Luis Masana, Olivier S. Descamps, Olov Wiklund, Robert A. Hegele, … Read more

Guidelines on management of dyslipidaemia 2016

These updated 2016 guidelines deal with the management of dyslipidaemias as an essential and integral part of CVD prevention. The guidance includes sections on: the evaluation of laboratory lipid and apolipoprotein parameters; treatment targets; lifestyle modifications to improve the plasma lipid profile; drugs for treatment of hypercholesterolaemia and hypertriglyceridaemia; drugs affecting HDL-cholesterol; managing dyslipidaemias in different … Read more


European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk A joint consensus statement from the European Society of Cardiology and the European Atherosclerosis Society Task Force. Publication in full Authors Ulf Landmesser, M. John Chapman, Michel … Read more